Cabaletta Bio Investor Relations Material
Latest events
Status Update
Cabaletta Bio
Investor Presentation
11 Jun, 2025
Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cabaletta Bio Inc
Access all reports
Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on developing engineered T cell therapies designed to treat autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania, and its shares are listed on the Nasdaq.
Key slides for Cabaletta Bio Inc
Investor Presentation
Cabaletta Bio Inc
Investor Presentation
Cabaletta Bio Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CABA
Country
🇺🇸 United States